Evidence map›Paper›PMID 39935538›Full record

ArticleFrontiers in cellular and infection microbiology2024

Transcriptional profiles analysis of effects of

Ningai Yang, Mingyang Li, Hong Yang, Jiaming Li, Tiantian Dang, Guangqi Li, Zhijun Zhao

Abstract read
In one paragraph

Article in Frontiers in cellular and infection microbiology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Ningai YangInstitute of Medical Sciences, General Hospital of Ningxia Medical University, Yinchuan, Ningxia, China.
Mingyang LiDepartment of Cardiology, Cardiovascular and Cerebrovascular Disease Hospital, General Hospital of Ningxia Medical University, Yinchuan, Ningxia, China.
Hong YangNingxia Hui Autonomous Region Hospital of Traditional Chinese Medicine and Research Institute of Traditional Chinese Medicine, Yinchuan, Ningxia, China.
Jiaming LiMedical Laboratory Center, General Hospital of Ningxia Medical University, Yinchuan, Ningxia, China.
Tiantian DangMedical Laboratory Center, General Hospital of Ningxia Medical University, Yinchuan, Ningxia, China.
Guangqi LiMedical Laboratory Center, General Hospital of Ningxia Medical University, Yinchuan, Ningxia, China.
Zhijun ZhaoNingxia Key Laboratory of Clinical Pathogenic Microorganisms, Yinchuan, Ningxia, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Methods: To investigate the mechanism of action of gonococcal ROP16 proteins in human macrophages, we constructed a lentivirus overexpressing ROP16 and established stably transfected cell lines. We then analyzed the gene transcriptional profiles of ROP16 II in THP-1 macrophages using transcriptome sequencing. Interaction networks were constructed by screening differentially expressed genes and performing gene function enrichment analysis. Results: As a result, five differentially expressed genes were identified: AAMDC, GPR158, RAD9A, STOML1, and STRA13. Immuno-featured differential analysis showed that type 17 T helper cells were more strongly correlated with GPR158 and STRA13, while CD8 T-cell was most strongly correlated with STOML1. Discussion: Therefore, we conclude that the ROP16 protein plays a pivotal role in THP-1 macrophage infection and these five differentially expressed genes may serve as promising molecular targets for the prevention or control of toxoplasmosis. These findings have significant implications for the diagnosis and treatment of toxoplasmosis.

Indexed as

MacrophagesProtozoan ProteinsToxoplasmaGene Expression ProfilingHumansProtein-Tyrosine KinasesTHP-1 CellsToxoplasmosisTranscriptomeProtein-Tyrosine KinasesProtozoan ProteinsRop16 protein, Toxoplasma gondiimacrophageRNA-seqROP16THP-1Toxoplasma gondii

Identifiers

PMID39935538
PMCPMC11810957

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.